Edition:
United Kingdom

Idorsia Ltd (IDIA.S)

IDIA.S on Swiss Exchange

24.92CHF
16 Sep 2019
Change (% chg)

-- (--)
Prev Close
CHF24.92
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
353,752
52-wk High
CHF28.00
52-wk Low
CHF15.20

Select another date:

Fri, Jul 26 2019

BRIEF-Idorsia Says Janssen Reports Positive Top-Line Phase 3 Results For Ponesimod

* JANSSEN REPORTS POSITIVE TOP-LINE PHASE 3 RESULTS FOR PONESIMOD IN ADULTS WITH RELAPSING MULTIPLE SCLEROSIS

BRIEF-Idorsia H1 US GAAP Net Loss At CHF 232 Mln

* UNCHANGED GUIDANCE FOR 2019: US GAAP OPERATING EXPENSES OF AROUND CHF 570 MILLION

UPDATE 1-Idorsia confirms 2019 spending plan as clinical trials "on track"

ZURICH, April 18 Swiss biotech Idorsia said on Thursday that all four clinical trials of its late-stage drug hopefuls were "on track" as it confirmed expectations of spending 570 million Swiss francs ($564 million) in the current year on the projects.

BRIEF-Idorsia Q1 US GAAP Net Loss Widens To CHF 106 Mln

* IDORSIA ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER 2019

Select another date: